TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 92 filers reported holding TRINITY BIOTECH PLC in Q2 2014. The put-call ratio across all filers is 10.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $3,000 | -40.0% | 254 | 0.0% | 0.00% | – |
Q2 2015 | $5,000 | 0.0% | 254 | 0.0% | 0.00% | – |
Q1 2015 | $5,000 | +25.0% | 254 | 0.0% | 0.00% | – |
Q4 2014 | $4,000 | -20.0% | 254 | 0.0% | 0.00% | – |
Q3 2014 | $5,000 | -16.7% | 254 | 0.0% | 0.00% | – |
Q2 2014 | $6,000 | 0.0% | 254 | 0.0% | 0.00% | – |
Q1 2014 | $6,000 | -25.0% | 254 | -34.4% | 0.00% | – |
Q3 2013 | $8,000 | +14.3% | 387 | 0.0% | 0.00% | – |
Q2 2013 | $7,000 | – | 387 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
Centaur Capital | 77,500 | $887,000 | 1.33% |
Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
RK Capital | 565,472 | $6,469,000 | 1.18% |
Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |